Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.710
0.00 (0.00%)
Oct 13, 2025, 1:33 PM EDT - Market open
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $142.81 million as of October 13, 2025. Its market cap has increased by 31.76% in one year.
Market Cap
142.81M
Enterprise Value
146.61M
1-Year Change
31.76%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $142.81M, an increase of 58.30%. That is a compound annual growth rate of 17.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 142.81M | 73.55% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |